Curated News: Medical Meetings

• share
• favorite_border

Using newly released cancer surveillance data, researchers at the American Cancer Society (ACS) found decreases in cancer diagnoses and proportion of early-stage diagnoses continued in 2021 in the United States during the second year of the COVID-19 pandemic. The proportion of late-stage diagnoses was lower in 2021 than in 2020, but has not returned to pre-pandemic levels. The findings will be presented at the annual American Society of Clinical Oncology (ASCO) Quality Care Symposium in San Francisco, September 27 – 28, 2024.

• share
• favorite_border

New research by scientists at the American Cancer Society (ACS) shows patients impacted by a wildfire disaster while recovering from lung cancer surgery have a longer in-hospital length of stay (LOS) than similar patients treated at the same facility at times when no disasters happened. The findings will be presented at the annual American Society of Clinical Oncology (ASCO) Quality Care Symposium in San Francisco, September 27 – 28, 2024.

• share
• favorite_border

A new study from researchers at the American Cancer Society (ACS) found that patients with stage 3 locally advanced non-small cell lung cancer (NSCLC) who received radiation treatment during a hurricane disaster were more likely to experience treatment completion delays. Researchers also reported that patients treated during a hurricane were more likely to receive higher total doses of radiation and complete more fractions. These findings will be presented at the annual American Society of Clinical Oncology (ASCO) Quality Care Symposium in San Francisco, September 27 – 28, 2024.

• share
• favorite_border

Patients diagnosed with major diseases, including cancer, often experience financial hardship due to high out-of-pocket medical costs in the United States. However, little is known about changes in income, wealth, and debt before and after major disease diagnoses. New data by researchers at the American Cancer Society (ACS) shows these families face various new types of debts, especially medical debt, after diagnoses. Moreover, newly diagnosed with cancer is associated with an increased likelihood of experiencing medical debt. The findings will be presented at the annual American Society of Clinical Oncology (ASCO) Quality Care Symposium in San Francisco, September 27 – 28, 2024.

• share
• favorite_border

New findings by researchers at the American Cancer Society (ACS) show total healthcare spending in the six months after a cancer diagnosis is considerable in the working-age population, with high out-of-pocket (OOP) costs for patients with private non-health maintenance organization (HMO) coverage. The study will be presented at the annual American Society of Clinical Oncology (ASCO) Quality Care Symposium in San Francisco, September 27 – 28, 2024.

• share
• favorite_border

Emergency physicians from Cedars-Sinai will present research findings and discuss advances in patient care at the American College of Emergency Physicians Scientific Assembly 24, Sept. 29-Oct. 1 in Las Vegas.

• share
• favorite_border

Scientists from the American Cancer Society (ACS) are presenting research studies at the 2024 Annual Meeting of the American Society of Clinical Oncology (ASCO) Quality Care Symposium (QCS) September 27-28 in San Francisco, CA.

• share
• favorite_border

ISPOR—The Professional Society for Health Economics and Outcomes Research announced the plenary sessions and speakers for ISPOR Europe 2024. The conference is the leading European conference for health economics and outcomes research (HEOR) and is scheduled for 17-20 November in Barcelona, Spain with the theme, “Generating Evidence Toward Health and Well-Being.”

• share
• favorite_border

Leaders from University Hospitals joined a select few of the nation’s leading healthcare systems at a White House forum on patient and workforce safety as part of World Patient Safety Day on September 17.

• share
• favorite_border

Reporters are invited to this live event on Obesity Management and Kidney Health. Experts from the American Society of Nephrology will take questions on the inaugural Kidney Health Guidance on managing obesity in kidney disease patients

• share
• favorite_border

The American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) proudly announces Ms. Candy Dolan as the 2024 Outstanding Service Award recipient for her dedicated service to her patients, technologists, residents and fellows, and AANEM.

• share
• favorite_border

During the European Society for Medical Oncology (ESMO) Congress, Saby George, MD, FACP, of Roswell Park Comprehensive Cancer Center presented findings on a novel two-agent treatment that more than doubled progression-free survival compared with single-agent treatment.

• share
• favorite_border

Treatment with a combination of haloperidol and lorazepam reduced symptoms of agitated delirium, a common end-of-life condition for patients with advanced cancers, compared with haloperidol alone, according to a new study led by researchers at The University of Texas MD Anderson Cancer Center.

• share
• favorite_border

A drug that delivers chemotherapy directly to tumors has shown impressive activity against some of the hardest-to-reach cancer cells: those that have spread to the brain in patients with advanced HER2-positive breast cancer. Research led by Dana-Farber Cancer Institute.

• share
• favorite_border

In an international multicenter randomized phase 3 clinical trial led by Dana-Farber Cancer Institute, researchers tested the addition of the immune checkpoint inhibitor (ICI) nivolumab to treatment with tivozanib for patients with advanced clear cell renal cell carcinoma.

• share
• favorite_border

The antibody-drug conjugate (ADC) puxitatug samrotecan (AZD8205) demonstrated a manageable safety profile consistent with similar ADCs and initial efficacy in heavily pretreated patients with advanced or metastatic solid tumors, according to interim data shared today at the 2024 European Society for Medical Oncology (ESMO) Congress by researchers from The University of Texas MD Anderson Cancer Center.

• share
• favorite_border

The American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) proudly announces Dr. Devon I. Rubin as the 2024 Innovation Award recipient for his forward-thinking contributions to the neuromuscular (NM) and electrodiagnostic (EDX) community.

• share
• favorite_border

Novel treatments, including targeted therapies and antibody drug conjugates, as well as research into improving quality of life for patients with breast cancer, headline studies led by Dana-Farber Cancer Institute and presented at the European Society of Medical Oncology (ESMO) Congress 2024 in Barcelona, Spain.

• share
• favorite_border

The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recent basic, translational and clinical cancer research from MD Anderson experts.

• share
• favorite_border

CRI is co-hosting CICON24 to illuminate pioneering advances in cancer immunotherapy research starting September 8 in National Harbor, MD.